Kymera Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024

January 2, 2024

https://www.globenewswire.com/news-release/2024/01/02/2802563/0/en/Kymera-Therapeutics-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference-on-Tuesday-January-9-2024.html

WATERTOWN, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ:KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 9, 2024, at 9:00 a.m. PT/12:00 p.m. ET. Nello Mainolfi, Ph.D., Founder, President and CEO, will provide an overview of the Company’s progress and anticipated milestones for 2024.

Read more at globenewswire.com

Related news for (KYMR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.